Mulberroside A: A Multi-Target Neuroprotective Agent in Alzheimer’s Disease via Cholinergic Restoration and PI3K/AKT Pathway Activation. The gene discussed is AKT1; the disease is early-onset autosomal dominant Alzheimer disease.